Literature DB >> 20232267

Formulation and optimization of orodispersible tablets of diazepam.

Khalid K Abed1, Ahmed A Hussein, Mowafaq M Ghareeb, Alaa A Abdulrasool.   

Abstract

Diazepam is one of the most prescribed benzodiazepines. The purpose of the present research was to optimize the formulation of orodispersible tablets of diazepam. Orodispersible tablets of diazepam were prepared using different types of superdisintegrants (Ac-Di-Sol, sodium starch glycolate, and crospovidone (CP)) and different types of subliming agents (camphor and ammonium bicarbonate (AB)) at different concentrations and two methods of tablets preparations (wet granulation and direct compression methods). The formulations were evaluated for flow properties, wetting time, hardness, friability, content uniformity, in vivo disintegration time (DT), release profiles, and buccal absorption tests. All formulations showed satisfactory mechanical strength except formula F5 which contains camphor and formula F9 which is prepared by direct compression method. The results revealed that the tablets containing CP as a superdisintegrant have good dissolution profile with shortest DT. The optimized formula F7 is prepared using 10% CP as a superdisintegrant and 20% AB as a subliming agent by wet granulation method which shows the shortest DT and good dissolution profile with acceptable stability. This study helps in revealing the effect of formulation processing variables on tablet properties. It can be concluded that the orodispersible tablets of diazepam with better biopharmaceutical properties than conventional tablets could be obtained using formula F7.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20232267      PMCID: PMC2850478          DOI: 10.1208/s12249-010-9387-y

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  13 in total

1.  Recent technological advances in oral drug delivery - a review.

Authors: 
Journal:  Pharm Sci Technolo Today       Date:  2000-04

Review 2.  Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies.

Authors:  Yourong Fu; Shicheng Yang; Seong Hoon Jeong; Susumu Kimura; Kinam Park
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2004       Impact factor: 4.889

3.  Modified conventional hard gelatin capsules as fast disintegrating dosage form in the oral cavity.

Authors:  Mesut Ciper; Roland Bodmeier
Journal:  Eur J Pharm Biopharm       Date:  2005-11-02       Impact factor: 5.571

4.  Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.

Authors:  Omaima A Sammour; Mohammed A Hammad; Nagia A Megrab; Ahmed S Zidan
Journal:  AAPS PharmSciTech       Date:  2006-06-16       Impact factor: 3.246

5.  Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose.

Authors:  Jinichi Fukami; Etsuo Yonemochi; Yasuo Yoshihashi; Katsuhide Terada
Journal:  Int J Pharm       Date:  2006-01-23       Impact factor: 5.875

6.  Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique.

Authors:  Mukesh Gohel; Madhabhai Patel; Avani Amin; Ruchi Agrawal; Rikita Dave; Nehal Bariya
Journal:  AAPS PharmSciTech       Date:  2004-04-26       Impact factor: 3.246

7.  Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-taste-masked granules by the compression method.

Authors:  T Ishikawa; Y Watanabe; N Utoguchi; M Matsumoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1999-10       Impact factor: 1.645

Review 8.  Drug-delivery products and the Zydis fast-dissolving dosage form.

Authors:  H Seager
Journal:  J Pharm Pharmacol       Date:  1998-04       Impact factor: 3.765

9.  Efficacy of diazepam as an anti-anxiety agent: meta-analysis of double-blind, randomized controlled trials carried out in Japan.

Authors:  Toshiya Inada; Shoko Nozaki; Ataru Inagaki; Toshiaki A Furukawa
Journal:  Hum Psychopharmacol       Date:  2003-08       Impact factor: 1.672

10.  Development of fast dispersible aceclofenac tablets: effect of functionality of superdisintegrants.

Authors:  C Mallikarjuna Setty; D V K Prasad; V R M Gupta; B Sa
Journal:  Indian J Pharm Sci       Date:  2008 Mar-Apr       Impact factor: 0.975

View more
  2 in total

1.  Development and optimization of carvedilol orodispersible tablets: enhancement of pharmacokinetic parameters in rabbits.

Authors:  Yazeed Hm Aljimaee; Abdel-Rahim M El-Helw; Osama Aa Ahmed; Khalid M El-Say
Journal:  Drug Des Devel Ther       Date:  2015-03-05       Impact factor: 4.162

2.  Development and Evaluation of Cannabidiol Orodispersible Tablets Using a 23-Factorial Design.

Authors:  Robert-Alexandru Vlad; Paula Antonoaea; Nicoleta Todoran; Emöke-Margit Rédai; Magdalena Bîrsan; Daniela-Lucia Muntean; Silvia Imre; Gabriel Hancu; Lénárd Farczádi; Adriana Ciurba
Journal:  Pharmaceutics       Date:  2022-07-14       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.